| 000 | 01753 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518060608.0 | ||
| 264 | 0 | _c20200207 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1553-7374 | ||
| 024 | 7 |
_a10.1371/journal.ppat.1008011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSurenaud, Mathieu | |
| 245 | 0 | 0 |
_aAnti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination. _h[electronic resource] |
| 260 |
_bPLoS pathogens _c09 2019 |
||
| 300 |
_ae1008011 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAIDS Vaccines _ximmunology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnti-Retroviral Agents |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aDendritic Cells _ximmunology |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xmethods |
| 650 | 0 | 4 |
_aEpitopes _ximmunology |
| 650 | 0 | 4 |
_aEpitopes, T-Lymphocyte _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _ximmunology |
| 650 | 0 | 4 |
_aHIV-1 _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aVaccination |
| 700 | 1 | _aMontes, Monica | |
| 700 | 1 | _aLindestam Arlehamn, Cecilia S | |
| 700 | 1 | _aSette, Alessandro | |
| 700 | 1 | _aBanchereau, Jacques | |
| 700 | 1 | _aPalucka, Karolina | |
| 700 | 1 | _aLelièvre, Jean-Daniel | |
| 700 | 1 | _aLacabaratz, Christine | |
| 700 | 1 | _aLévy, Yves | |
| 773 | 0 |
_tPLoS pathogens _gvol. 15 _gno. 9 _gp. e1008011 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.ppat.1008011 _zAvailable from publisher's website |
| 999 |
_c30090228 _d30090228 |
||